亞太地區真實世界證據解決方案市場規模、份額和行業趨勢分析報告：按組成部分、治療領域、最終用戶、應用程序、國家/地區、增長預測，2022-2028 年

在預測期內（2022 年至 2028 年），亞太地區的真實世界證據解決方案市場預計將以 9.0% 的複合年增長率增長。

這些信息可以改進基於質量的報銷計劃，以慶祝良好的結果，並幫助付款人和消費者更明智地討論保險範圍。 患者登記處、產品登記處和索賠登記處等臨床登記處是 RWD 的額外豐富信息來源。 這些是創建 RWE 並利用它們促進上市後監督和監管的重要資源。

在監管和報銷決策中使用 RWE 是亞太地區各級政府和監管機構正在做的事情。 一些公司已經發布了正式公告，並正在進入試點項目，以展示 RWE 的優勢和能力。 其他人仍處於他們方法的早期階段。 由於對支持中國醫療保健決策的經驗數據的需求不斷增長，許多新的數據源已經開發出來。 健康經濟學、流行病學和結果研究尚未全面評估當前可用的真實世界醫療保健數據源。 通過這種方式，醫療保健領域越來越多地使用真實世界證據正在推動亞太地區真實世界證據解決方案市場的增長。

中國市場將在 2021 年主導亞太國家真實世界證據解決方案市場，並將在 2028 年之前保持主導地位，到 2028 年市場價值將達到 46.577 億美元。預計將實現 此外，印度市場預計在 2022 年至 2028 年期間將以 9.7% 的複合年增長率增長。

市場根據組件細分為服務和數據集。 治療領域分為腫瘤學、心髒病學、神經病學、糖尿病、呼吸病學等。 基於最終用戶，市場分為醫療保健公司、醫療保健支付者、醫療保健提供者等。 按應用劃分，市場分為藥物開發和批准、醫療器械開發和批准、報銷、補償和監管決策，以及市場安全和不良事件監測。 按國家/地區劃分，市場分為中國、日本、印度、韓國、新加坡、馬來西亞和亞太地區其他地區。

內容

第1章市場範圍與研究方法

• 市場定義
• 目的
• 市場規模
• 細分
  • 亞太真實世界證據解決方案市場，按組成部分
  • 亞太地區真實世界證據解決方案市場，按治療領域劃分
  • 亞太地區真實世界證據解決方案市場：按最終用戶分類
  • 亞太地區真實世界證據解決方案市場：按應用分類
  • 亞太地區真實世界證據解決方案市場：按國家/地區分類
• 調查方法

第 2 章市場概述

• 簡介
  • 概覽
    • 市場情景和構成
• 影響市場的主要因素
  • 市場驅動因素
  • 市場製約因素

第 3 章在現實世界證據解決方案市場中演變的策略

第 4 章亞太真實世界證據解決方案市場：按組件分類

• 亞太服務市場：按國家/地區分類
• 亞太數據集市場：按國家/地區分類

第 5 章亞太真實世界證據解決方案市場：按治療領域分類

• 亞太腫瘤學市場：按國家/地區分類
• 按國家/地區劃分的亞太心髒病學市場趨勢
• 按國家/地區劃分的亞太地區神經病學市場趨勢
• 亞太地區糖尿病市場：按國家/地區分類
• 亞太呼吸系統市場：按國家/地區分類
• 亞太地區的其餘市場：按國家/地區分類

第 6 章亞太真實世界證據解決方案市場（按最終用戶）

• 亞太地區醫療保健企業市場：按國家/地區分類
• 亞太地區醫療保健付款人市場：按國家/地區分類
• 按國家/地區劃分的亞太地區醫療保健提供商市場
• 亞太地區的其餘市場：按國家/地區分類

第 7 章：按應用分列的亞太真實世界證據解決方案市場

• 按國家/地區劃分的亞太藥物開發和批准市場
• 亞太地區的醫療器械開發和審批市場：按國家/地區分類
• 按國家/地區劃分的亞太報銷、補償和監管決策市場
• 亞太地區上市後安全和不良事件監測市場：按國家/地區分類

第 8 章亞太地區真實世界證據解決方案的國家/地區市場

• 中國真實世界證據解決方案市場
  • 中國真實世界證據解決方案市場的組成部分
  • 中國的真實世界證據解決方案市場：按治療領域分類
  • 中國真實世界證據解決方案市場：按最終用戶分類
  • 中國的真實世界證據解決方案市場：按應用分類
• 日本的真實世界證據解決方案市場
  • 日本真實世界證據解決方案市場：按組件分類
  • 日本真實世界證據解決方案市場：按治療領域分類
  • 真實世界證據解決方案的日本市場（按最終用戶分類）
  • 日本真實世界證據解決方案市場：按應用分類
• 印度的真實世界證據解決方案市場
  • 印度真實世界證據解決方案市場：按組成部分
  • 印度真實世界證據解決方案市場（按治療領域）
  • 印度真實世界證據解決方案市場（按最終用戶）
  • 印度的真實世界證據解決方案市場（按應用分類）
• 韓國真實世界證據解決方案市場
  • 韓國真實世界證據解決方案市場：按組成部分
  • 韓國真實世界證據解決方案市場（按治療領域分類）
  • 韓國真實世界證據解決方案市場（按最終用戶）
  • 韓國真實世界證據解決方案市場：按應用分類
• 新加坡的真實世界證據解決方案市場
  • 新加坡真實世界證據解決方案市場：按組成部分
  • 新加坡真實世界證據解決方案市場（按治療領域）
  • 新加坡真實世界證據解決方案市場：按最終用戶分類
  • 新加坡真實世界證據解決方案市場（按應用）
• 馬來西亞真實世界證據解決方案市場
  • 馬來西亞真實世界證據解決方案市場：按組成部分
  • 馬來西亞真實世界證據解決方案市場：按治療領域分類
  • 馬來西亞真實世界證據解決方案市場：按最終用戶分類
  • 馬來西亞真實世界證據解決方案市場（按應用）
• 亞太地區其他真實世界證據解決方案市場
  • 亞太地區其他真實世界證據解決方案市場：按組件分類
  • 亞太地區其他真實世界證據解決方案市場（按治療領域）
  • 亞太地區其他真實世界證據解決方案市場：按最終用戶分類
  • 亞太地區其他真實世界證據解決方案市場：按應用分類

第9章：公司簡介

• IBM Corporation
• Oracle Corporation
• PPD, Inc.（Thermo Fisher Scientific, Inc.）
• UnitedHealth Group, Inc.（Optum, Inc.）
• Syneos Health, Inc.
• IQVIA Holdings, Inc.
• Medpace Holdings, Inc.
• ICON plc
• PerkinElmer, Inc.
• Parexel International Corporation（Phoenix Parentco, Inc.）

The Asia Pacific Real World Evidence Solutions Market would witness market growth of 9.0% CAGR during the forecast period (2022-2028).

The major pharmaceutical companies use a clinico-genomic database containing tumor sequencing data for cancer discovery investigations and the development of targeted drugs. As a result, businesses are able to perform a modest number of clinical trials for the uncommon biomarker-defined group while also expanding their range of indications. Thus, it shows that the market for real-world evidence solutions will rise in the coming years.

RWE can add patient-generated data, like biometric data or patient-reported outcomes (PROs), that is simpler to obtain between doctor visits to traditional outcome measurements during clinical studies. RWE is able to monitor quality and result metrics across organizations. For example, RWE can notify administrators of the benchmarking performance of their physicians and the performance of their overall health system compared to others.

This information can improve quality-based reimbursement schemes that honor good results and can assist payers and consumers in having more informed coverage discussions. Clinical registries, like the patient, product, and claims registries, are rich sources of RWD addition to that. They are essential resources for producing RWE and utilizing it to facilitate post-market investigation and surveillance.

Using RWE for regulatory & reimbursement decision-making is a journey that governments and regulators around the Asia Pacific are at various levels of. To show RWE's advantages and capabilities, some have already released formal advice and are moving on with pilot projects. Others are still in the initial phases of those approaches. Due to China's growing need for empirical data to support healthcare decisions, many new data sources have developed. Health economics, epidemiology, and outcomes research have not comprehensively assessed the real-world healthcare data sources that are currently available. Thus, the increased utilization of real world evidence in healthcare sector is driving the growth of Asia Pacific real world evidence solutions market.

The China market dominated the Asia Pacific Real World Evidence Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $4,657.7 million by 2028.The Japan market is estimated to grow a CAGR of 8.4% during (2022 - 2028). Additionally, The India market would experience a CAGR of 9.7% during (2022 - 2028).

Based on Component, the market is segmented into Services and Data Set. Based on Therapeutic Area, the market is segmented into Oncology, Cardiology, Neurology, Diabetes, Respiratory and Others. Based on End-user, the market is segmented into Healthcare Companies, Healthcare Payers, Healthcare Providers and Others. Based on Application, the market is segmented into Drug Development & Approvals, Medical Device Development & Approvals, Reimbursement/Coverage & Regulatory Decision Making and Post Market Safety & Adverse Events Monitoring. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBM Corporation, Oracle Corporation, Medpace Holdings, Inc., IQVIA Holdings, Inc., ICON plc, PerkinElmer, Inc., Parexel International Corporation (Phoenix Parentco, Inc.), PPD, Inc. (Thermo Fisher Scientific, Inc.), UnitedHealth Group, Inc. (Optum, Inc.), and Syneos Health, Inc.

Scope of the Study

Market Segments covered in the Report:

By Component

• Services
• Data Set

By Therapeutic Area

• Oncology
• Cardiology
• Neurology
• Diabetes
• Respiratory
• Others

By End-user

• Healthcare Companies
• Healthcare Payers
• Healthcare Providers
• Others

By Application

• Drug Development & Approvals
• Medical Device Development & Approvals
• Reimbursement/Coverage & Regulatory Decision Making
• Post Market Safety & Adverse Events Monitoring

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Companies Profiled

• IBM Corporation
• Oracle Corporation
• Medpace Holdings, Inc.
• IQVIA Holdings, Inc.
• ICON plc
• PerkinElmer, Inc.
• Parexel International Corporation (Phoenix Parentco, Inc.)
• PPD, Inc. (Thermo Fisher Scientific, Inc.)
• UnitedHealth Group, Inc. (Optum, Inc.)
• Syneos Health, Inc.

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Asia Pacific Real World Evidence Solutions Market, by Component
  • 1.4.2 Asia Pacific Real World Evidence Solutions Market, by Therapeutic Area
  • 1.4.3 Asia Pacific Real World Evidence Solutions Market, by End-user
  • 1.4.4 Asia Pacific Real World Evidence Solutions Market, by Application
  • 1.4.5 Asia Pacific Real World Evidence Solutions Market, by Country
• 1.5 Methodology for the research

Chapter 2. Market Overview

• 2.1 Introduction
  • 2.1.1 Overview
    • 2.1.1.1 Market Scenario and Composition
• 2.2 Key Factors Impacting the Market
  • 2.2.1 Market Drivers
  • 2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Real World Evidence Solutions Market

Chapter 4. Asia Pacific Real World Evidence Solutions Market by Component

• 4.1 Asia Pacific Services Market by Country
• 4.2 Asia Pacific Data Set Market by Country

Chapter 5. Asia Pacific Real World Evidence Solutions Market by Therapeutic Area

• 5.1 Asia Pacific Oncology Market by Country
• 5.2 Asia Pacific Cardiology Market by Country
• 5.3 Asia Pacific Neurology Market by Country
• 5.4 Asia Pacific Diabetes Market by Country
• 5.5 Asia Pacific Respiratory Market by Country
• 5.6 Asia Pacific Others Market by Country

Chapter 6. Asia Pacific Real World Evidence Solutions Market by End-user

• 6.1 Asia Pacific Healthcare Companies Market by Country
• 6.2 Asia Pacific Healthcare Payers Market by Country
• 6.3 Asia Pacific Healthcare Providers Market by Country
• 6.4 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Real World Evidence Solutions Market by Application

• 7.1 Asia Pacific Drug Development & Approvals Market by Country
• 7.2 Asia Pacific Medical Device Development & Approvals Market by Country
• 7.3 Asia Pacific Reimbursement/Coverage & Regulatory Decision Making Market by Country
• 7.4 Asia Pacific Post Market Safety & Adverse Events Monitoring Market by Country

Chapter 8. Asia Pacific Real World Evidence Solutions Market by Country

• 8.1 China Real World Evidence Solutions Market
  • 8.1.1 China Real World Evidence Solutions Market by Component
  • 8.1.2 China Real World Evidence Solutions Market by Therapeutic Area
  • 8.1.3 China Real World Evidence Solutions Market by End-user
  • 8.1.4 China Real World Evidence Solutions Market by Application
• 8.2 Japan Real World Evidence Solutions Market
  • 8.2.1 Japan Real World Evidence Solutions Market by Component
  • 8.2.2 Japan Real World Evidence Solutions Market by Therapeutic Area
  • 8.2.3 Japan Real World Evidence Solutions Market by End-user
  • 8.2.4 Japan Real World Evidence Solutions Market by Application
• 8.3 India Real World Evidence Solutions Market
  • 8.3.1 India Real World Evidence Solutions Market by Component
  • 8.3.2 India Real World Evidence Solutions Market by Therapeutic Area
  • 8.3.3 India Real World Evidence Solutions Market by End-user
  • 8.3.4 India Real World Evidence Solutions Market by Application
• 8.4 South Korea Real World Evidence Solutions Market
  • 8.4.1 South Korea Real World Evidence Solutions Market by Component
  • 8.4.2 South Korea Real World Evidence Solutions Market by Therapeutic Area
  • 8.4.3 South Korea Real World Evidence Solutions Market by End-user
  • 8.4.4 South Korea Real World Evidence Solutions Market by Application
• 8.5 Singapore Real World Evidence Solutions Market
  • 8.5.1 Singapore Real World Evidence Solutions Market by Component
  • 8.5.2 Singapore Real World Evidence Solutions Market by Therapeutic Area
  • 8.5.3 Singapore Real World Evidence Solutions Market by End-user
  • 8.5.4 Singapore Real World Evidence Solutions Market by Application
• 8.6 Malaysia Real World Evidence Solutions Market
  • 8.6.1 Malaysia Real World Evidence Solutions Market by Component
  • 8.6.2 Malaysia Real World Evidence Solutions Market by Therapeutic Area
  • 8.6.3 Malaysia Real World Evidence Solutions Market by End-user
  • 8.6.4 Malaysia Real World Evidence Solutions Market by Application
• 8.7 Rest of Asia Pacific Real World Evidence Solutions Market
  • 8.7.1 Rest of Asia Pacific Real World Evidence Solutions Market by Component
  • 8.7.2 Rest of Asia Pacific Real World Evidence Solutions Market by Therapeutic Area
  • 8.7.3 Rest of Asia Pacific Real World Evidence Solutions Market by End-user
  • 8.7.4 Rest of Asia Pacific Real World Evidence Solutions Market by Application

Chapter 9. Company Profiles

• 9.1 IBM Corporation
  • 9.1.1 Company Overview
  • 9.1.2 Financial Analysis
  • 9.1.3 Regional & Segmental Analysis
  • 9.1.4 Research & Development Expenses
  • 9.1.5 Recent strategies and developments:
    • 9.1.5.1 Acquisition and Mergers:
  • 9.1.6 SWOT Analysis
• 9.2 Oracle Corporation
  • 9.2.1 Company Overview
  • 9.2.2 Financial Analysis
  • 9.2.3 Segmental and Regional Analysis
  • 9.2.4 Research & Development Expense
  • 9.2.5 SWOT Analysis
• 9.3 PPD, Inc. (Thermo Fisher Scientific, Inc.)
  • 9.3.1 Company Overview
  • 9.3.2 Financial Analysis
  • 9.3.3 Segmental and Regional Analysis
  • 9.3.4 Research & Development Expense
  • 9.3.5 SWOT Analysis
• 9.4 UnitedHealth Group, Inc. (Optum, Inc.)
  • 9.4.1 Company Overview
  • 9.4.2 Financial Analysis
  • 9.4.3 Segmental Analysis
• 9.5 Syneos Health, Inc.
  • 9.5.1 Company Overview
  • 9.5.2 Financial Analysis
  • 9.5.3 Segmental and Regional Analysis
  • 9.5.4 Recent strategies and developments:
    • 9.5.4.1 Acquisition and Mergers:
• 9.6 IQVIA Holdings, Inc.
  • 9.6.1 Company Overview
  • 9.6.2 Financial Analysis
  • 9.6.3 Segmental and Regional Analysis
  • 9.6.4 Recent strategies and developments:
    • 9.6.4.1 Partnerships, Collaborations, and Agreements:
    • 9.6.4.2 Acquisition and Mergers:
• 9.7 Medpace Holdings, Inc.
  • 9.7.1 Company Overview
  • 9.7.2 Financial Analysis
• 9.8 ICON plc
  • 9.8.1 Company Overview
  • 9.8.2 Financial Analysis
  • 9.8.3 Regional Analysis
  • 9.8.4 Recent strategies and developments:
    • 9.8.4.1 Acquisition and Mergers:
• 9.9 PerkinElmer, Inc.
  • 9.9.1 Company Overview
  • 9.9.2 Financial Analysis
  • 9.9.3 Segmental and Regional Analysis
  • 9.9.4 Research & Development Expense
  • 9.9.5 Recent strategies and developments:
    • 9.9.5.1 Product Launches and Product Expansions:
• 9.10. Parexel International Corporation (Phoenix Parentco, Inc.)
  • 9.10.1 Company Overview
  • 9.10.2 Recent strategies and developments:
    • 9.10.2.1 Partnerships, Collaborations, and Agreements:

LIST OF TABLES

• TABLE 1 Asia Pacific Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 2 Asia Pacific Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 3 Asia Pacific Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 4 Asia Pacific Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 5 Asia Pacific Services Market by Country, 2018 - 2021, USD Million
• TABLE 6 Asia Pacific Services Market by Country, 2022 - 2028, USD Million
• TABLE 7 Asia Pacific Data Set Market by Country, 2018 - 2021, USD Million
• TABLE 8 Asia Pacific Data Set Market by Country, 2022 - 2028, USD Million
• TABLE 9 Asia Pacific Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 10 Asia Pacific Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 11 Asia Pacific Oncology Market by Country, 2018 - 2021, USD Million
• TABLE 12 Asia Pacific Oncology Market by Country, 2022 - 2028, USD Million
• TABLE 13 Asia Pacific Cardiology Market by Country, 2018 - 2021, USD Million
• TABLE 14 Asia Pacific Cardiology Market by Country, 2022 - 2028, USD Million
• TABLE 15 Asia Pacific Neurology Market by Country, 2018 - 2021, USD Million
• TABLE 16 Asia Pacific Neurology Market by Country, 2022 - 2028, USD Million
• TABLE 17 Asia Pacific Diabetes Market by Country, 2018 - 2021, USD Million
• TABLE 18 Asia Pacific Diabetes Market by Country, 2022 - 2028, USD Million
• TABLE 19 Asia Pacific Respiratory Market by Country, 2018 - 2021, USD Million
• TABLE 20 Asia Pacific Respiratory Market by Country, 2022 - 2028, USD Million
• TABLE 21 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
• TABLE 22 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
• TABLE 23 Asia Pacific Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 24 Asia Pacific Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 25 Asia Pacific Healthcare Companies Market by Country, 2018 - 2021, USD Million
• TABLE 26 Asia Pacific Healthcare Companies Market by Country, 2022 - 2028, USD Million
• TABLE 27 Asia Pacific Healthcare Payers Market by Country, 2018 - 2021, USD Million
• TABLE 28 Asia Pacific Healthcare Payers Market by Country, 2022 - 2028, USD Million
• TABLE 29 Asia Pacific Healthcare Providers Market by Country, 2018 - 2021, USD Million
• TABLE 30 Asia Pacific Healthcare Providers Market by Country, 2022 - 2028, USD Million
• TABLE 31 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
• TABLE 32 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
• TABLE 33 Asia Pacific Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 34 Asia Pacific Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 35 Asia Pacific Drug Development & Approvals Market by Country, 2018 - 2021, USD Million
• TABLE 36 Asia Pacific Drug Development & Approvals Market by Country, 2022 - 2028, USD Million
• TABLE 37 Asia Pacific Medical Device Development & Approvals Market by Country, 2018 - 2021, USD Million
• TABLE 38 Asia Pacific Medical Device Development & Approvals Market by Country, 2022 - 2028, USD Million
• TABLE 39 Asia Pacific Reimbursement/Coverage & Regulatory Decision Making Market by Country, 2018 - 2021, USD Million
• TABLE 40 Asia Pacific Reimbursement/Coverage & Regulatory Decision Making Market by Country, 2022 - 2028, USD Million
• TABLE 41 Asia Pacific Post Market Safety & Adverse Events Monitoring Market by Country, 2018 - 2021, USD Million
• TABLE 42 Asia Pacific Post Market Safety & Adverse Events Monitoring Market by Country, 2022 - 2028, USD Million
• TABLE 43 Asia Pacific Real World Evidence Solutions Market by Country, 2018 - 2021, USD Million
• TABLE 44 Asia Pacific Real World Evidence Solutions Market by Country, 2022 - 2028, USD Million
• TABLE 45 China Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 46 China Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 47 China Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 48 China Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 49 China Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 50 China Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 51 China Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 52 China Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 53 China Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 54 China Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 55 Japan Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 56 Japan Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 57 Japan Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 58 Japan Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 59 Japan Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 60 Japan Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 61 Japan Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 62 Japan Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 63 Japan Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 64 Japan Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 65 India Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 66 India Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 67 India Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 68 India Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 69 India Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 70 India Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 71 India Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 72 India Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 73 India Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 74 India Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 75 South Korea Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 76 South Korea Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 77 South Korea Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 78 South Korea Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 79 South Korea Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 80 South Korea Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 81 South Korea Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 82 South Korea Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 83 South Korea Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 84 South Korea Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 85 Singapore Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 86 Singapore Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 87 Singapore Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 88 Singapore Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 89 Singapore Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 90 Singapore Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 91 Singapore Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 92 Singapore Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 93 Singapore Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 94 Singapore Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 95 Malaysia Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 96 Malaysia Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 97 Malaysia Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 98 Malaysia Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 99 Malaysia Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 100 Malaysia Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 101 Malaysia Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 102 Malaysia Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 103 Malaysia Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 104 Malaysia Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 105 Rest of Asia Pacific Real World Evidence Solutions Market, 2018 - 2021, USD Million
• TABLE 106 Rest of Asia Pacific Real World Evidence Solutions Market, 2022 - 2028, USD Million
• TABLE 107 Rest of Asia Pacific Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
• TABLE 108 Rest of Asia Pacific Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
• TABLE 109 Rest of Asia Pacific Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
• TABLE 110 Rest of Asia Pacific Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
• TABLE 111 Rest of Asia Pacific Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
• TABLE 112 Rest of Asia Pacific Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
• TABLE 113 Rest of Asia Pacific Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
• TABLE 114 Rest of Asia Pacific Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
• TABLE 115 Key information - IBM Corporation
• TABLE 116 Key Information - Oracle Corporation
• TABLE 117 Key Information - PPD, Inc.
• TABLE 118 Key Information - UnitedHealth Group, Inc.
• TABLE 119 Key Information - Syneos Health, Inc.
• TABLE 120 Key information - IQVIA Holdings, Inc.
• TABLE 121 key Information - Medpace Holdings, Inc.
• TABLE 122 key Information - PerkinElmer, Inc.
• TABLE 123 Key Information - PAREXEL International Corporation

List of Figures

• FIG 1 Methodology for the research
• FIG 2 Swot analysis: IBM Corporation
• FIG 3 SWOT analysis: Oracle Corporation
• FIG 4 Swot analysis: thermo fisher scientific, inc.